Profil

BAUDOUX Etienne

Département de médecine interne > Laboratoire de thérapie cellulaire et génique (LTCG)

See author's contact details
ORCID
0000-0002-1730-8357
Main Referenced Co-authors
Beguin, Yves  (60)
Lechanteur, Chantal  (34)
Baron, Frédéric  (29)
Briquet, Alexandra  (22)
Fillet, Georges  (21)
Main Referenced Keywords
Humans (19); Male (14); Middle Aged (14); Adult (13); Female (13);
Main Referenced Unit & Research Centers
GIGA-I3 - Giga-Infection, Immunity and Inflammation - ULiège [BE] (1)
Main Referenced Disciplines
Hematology (74)
Surgery (12)
Urology & nephrology (7)
Laboratory medicine & medical technology (4)
Gastroenterology & hepatology (3)

Publications (total 95)

The most downloaded
1025 downloads
Klykens, J., Pirnay, J., Verbeken, G., GIET, O., BAUDOUX, E., Jashari, R., Vanderkelen, A., & Ectors, N. (2013). Cleanrooms and tissue banking how happy I could be with either GMP or GTP? Cell and Tissue Banking. doi:10.1007/s10561-012-9355-8 https://hdl.handle.net/2268/140648

The most cited

176 citations (Scopus®)

Baron, F., Lechanteur, C., Willems, E., Bruck, F., Baudoux, E., Seidel, L., Vanbellinghen, J.-F., Hafraoui, K., LEJEUNE, M., Gothot, A., Fillet, G., & Beguin, Y. (2010). Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Biology of Blood and Marrow Transplantation, 16 (6), 838-47. doi:10.1016/j.bbmt.2010.01.011 https://hdl.handle.net/2268/77204

Articles in scientific journals with peer reviewing

Chabannon, C., Benakli, M., Alexandrova, K., Coze, C., Dalle, J.-H., Giraud, C., Huynh, P., Kanouni, T., Kanold, J., Lesieur, I., Levavasseur, A., Yakoub-Agha, I., & Baudoux, E. (2024). Cytaphérèses pédiatriques (atelier SFGM-TC). Bulletin du Cancer. doi:10.1016/j.bulcan.2023.12.008
Peer Reviewed verified by ORBi

Delgadillo, J., Kerkelä, E., Waters, A., van den Akker, E., LECHANTEUR, C., BAUDOUX, E., Gardiner, N., De Vos, J., & Vives, J. (2023). A management model in blood, tissue and cell establishments to ensure rapid and sustainable patient access to advanced therapy medicinal products in Europe. Cytotherapy. doi:10.1016/j.jcyt.2023.08.001
Peer Reviewed verified by ORBi

Servais, S., Baron, F., LECHANTEUR, C., Seidel, L., BAUDOUX, E., BRIQUET, A., Selleslag, D., Maertens, J., Poire, X., Schroyens, W., Graux, C., De Becker, A., Zachee, P., Ory, A., Herman, J., Kerre, T., & Beguin, Y. (2023). Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis. Frontiers in Immunology, 14. doi:10.3389/fimmu.2023.1106464
Peer Reviewed verified by ORBi

Reenaers, C., GILLARD, R., Coimbra, C., GILLARD, R., Meunier, P., LECHANTEUR, C., BAUDOUX, E., BOUTAFFALA, L., Beguin, Y., & Louis, E. (2023). Clinical and MRI evolution after local injection of bone marrow-derived mesenchymal stem cells in perianal fistulae in Crohn’s disease: results from a prospective monocentric study. Journal of Crohn's and Colitis, 17, 728-737. doi:10.1093/ecco-jcc/jjac192
Peer Reviewed verified by ORBi

GREGOIRE, C.* , LAYIOS, N.* , LAMBERMONT, B., LECHANTEUR, C., BRIQUET, A., Bettonville, V., BAUDOUX, E., THYS, M., Dardenne, N., Misset, B.* , & BEGUIN, Y.*. (04 July 2022). Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial. Frontiers in Immunology, 13, 932360. doi:10.3389/fimmu.2022.932360
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Forcade, E., Bacquet, S., Ballot, C., Capin, L., GARNIER, F., Giraud, C., Guérout-Vérité, M.-A., Letellier, C., MAGNANI, A., MAMEZ, A.-C., NASONE, J., Sinayoko, M., BAUDOUX, E., MIALOU, V., Yakoub-Agha, I., & Calmels, B. (2022). Modalités et impact de la cryopréservation des greffons allogéniques en contexte pandémique : recommandations de la Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bulletin du Cancer. doi:10.1016/j.bulcan.2022.03.015
Peer Reviewed verified by ORBi

VIEUJEAN, S., LOLY, J.-P., BOUTAFFALA, L., MEUNIER, P., REENAERS, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., BEGUIN, Y., & LOUIS, E. (2022). Mesenchymal Stem Cell Injection in Crohn's Disease Strictures: a phase I-II clinical study. Journal of Crohn's and Colitis, 16, 506-510. doi:10.1093/ecco-jcc/jjab154
Peer Reviewed verified by ORBi

LECHANTEUR, C., BRIQUET, A., Bettonville, V., BAUDOUX, E., & BEGUIN, Y. (2021). MSC Manufacturing for Academic Clinical Trials: From a Clinical-Grade to a Full GMP-Compliant Process. Cells, 10, 1320. doi:10.3390/cells10061320
Peer Reviewed verified by ORBi

Ingels, J., De Smet, S., Heyns, K., Lootens, N., Segaert, J., Taghon, T., Leclercq, G., Vermaelen, K., WILLEMS, E., BAUDOUX, E., Kerre, T., Baron, F., & Vandekerckhove, B. (2021). Treatment of a patient with severe cytomegalovirus (CMV) infection after haploidentical stem cell transplantation with donor-derived CMV-specific T cells. Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine, 76, 482-486. doi:10.1080/17843286.2020.1752446
Peer reviewed

Jöris, M., Paulson, K., Foley, L., Duffy, M., Querol, S., Gomez, S., & BAUDOUX, E. (2021). Worldwide survey on key indicators for public cord blood banking technologies: By the World Marrow DonorAssociation Cord Blood Working Group. Stem Cells Translational Medicine, 10, 222-229. doi:10.1002/sctm.20-0246
Peer Reviewed verified by ORBi

Calmels, B., Gautier, E., Magnani, A., Magrin, E., Mamez, A. C., Vaissié, A., Yakoub-Agha, I., & BAUDOUX, E. (2020). Procédé de préparation, contrôles de qualité et spécifications des immunosélections CD34+ : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. doi:10.1016/j.bulcan.2020.06.005
Peer Reviewed verified by ORBi

Dalle, J.-H., BAUDOUX, E., Caillat-Zucman, S., Colledani, F., PEREIRA-MARTINS, M., Bruno, B., Nguyen, S., Robin, M., & Rubio, M. T. (April 2020). Le développement des cellules CAR-T et autre thérapie génique : tout n’est pas si simple [letter to the editor]. Bulletin du Cancer, 107 (4), 408-409. doi:10.1016/j.bulcan.2020.03.002
Peer Reviewed verified by ORBi

HAUZEUR, J.-P., LECHANTEUR, C., BAUDOUX, E., De Maertelaer, V., Pather, S., Katz, R., Malaise, M., Ino, J., & Beguin, Y. (2020). Did Osteoblastic Cell Therapy Improve the Prognosis of Prefracture Osteonecrosis of the Femoral Head? A Randomized, Controlled Trial. Clinical Orthopaedics and Related Research, 478, 1307-1315.
Peer Reviewed verified by ORBi

De Vos, J., BAUDOUX, E., Bay, J.-O., Calmels, B., Cras, A., El Cheikh, J., Guerout-Verite, M.-A., Lacassagne, M.-N., Lamure, S., Letellier, C., Menard, A.-L., Daguindau, E., Poiré, X., Yakoub-Agha, I., & Guillaume, T. (December 2019). Injections de lymphocytes du donneur (DLI) : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer, 106, 35-S39. doi:10.1016/j.bulcan.2018.10.002
Peer Reviewed verified by ORBi

ERPICUM, P., WEEKERS, L., DETRY, O., BONVOISIN, C., DELBOUILLE, M.-H., GREGOIRE, C., BAUDOUX, E., BRIQUET, A., LECHANTEUR, C., MAGGIPINTO, G., SOMJA, J., Pottel, H., Baron, F., Jouret, F., & BEGUIN, Y. (2019). Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study. Kidney International, 95, 693-707. doi:10.1016/j.kint.2018.08.046
Peer Reviewed verified by ORBi

de Jamblinne, Y., BAUDOUX, E., Delo, C., & Coppieters, Y. (August 2018). Influence de facteurs obstétricaux sur les caractéristiques des greffons de sang de cordon ombilical. Gynécologie Obstétrique et Fertilité, 46, 639-644. doi:10.1016/j.gofs.2018.07.005
Peer Reviewed verified by ORBi

HAUZEUR, J.-P., De Maertelaer, V., BAUDOUX, E., MALAISE, M., Beguin, Y., & Gangji, V. (2018). Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial. International Orthopaedics, 42, 1429-1435. doi:10.1007/s00264-017-3650-8
Peer Reviewed verified by ORBi

Servais, S., Baron, F., LECHANTEUR, C., SEIDEL, L., Selleslag, D., Maertens, J., BAUDOUX, E., Zachee, P., Van Gelder, M., Noens, L., Kerre, T., Lewalle, P., Schroyens, W., ORY, A., & Beguin, Y. (2018). Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graftversus- host disease: A multicenter prospective study. Oncotarget, 9 (29), 20590-20604. doi:10.18632/oncotarget.25020
Peer Reviewed verified by ORBi

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., SOMJA, J., BLETARD, N., Briquet, A., LECHANTEUR, C., GIET, O., BAUDOUX, E., Hannon, M., Baron, F., & Beguin, Y. (July 2017). Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study. Journal of Hepatology, 67 (1), 47-55. doi:10.1016/j.jhep.2017.03.001
Peer Reviewed verified by ORBi

GREGOIRE, C., LECHANTEUR, C., BRIQUET, A., BAUDOUX, E., BARON, F., LOUIS, E., & BEGUIN, Y. (2017). Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases. Alimentary Pharmacology and Therapeutics, 45, 205-221. doi:10.1111/apt.13864
Peer Reviewed verified by ORBi

Nikolajeva, O., Rocha, V., Danby, R., Ruggeri, A., Volt, F., BAUDOUX, E., Gomez, S. G., Kögler, G., Larghero, J., Lecchi, L., Sanchez Martinez, M., Navarrete, C., Pouthier, F., Querol, S., Kenzey, C., Szydlo, R., Gluckman, E., & Madrigal, A. (2017). Umbilical Cord Blood Cytomegalovirus Serostatus Does Not Have an Impact on Outcomes of Umbilical Cord Blood Transplantation for Acute Leukemia. Biology of Blood and Marrow Transplantation. doi:10.1016/j.bbmt.2017.06.022
Peer Reviewed verified by ORBi

Boulanger, F., Decot, V., Bulliard, G., Calmels, B., Giraud, C., Lacassagne, M. N., Magnani, A., Pouthier, F., Thibert, J. B., Tirefort, Y., Yakoub-Agha, I., & BAUDOUX, E. (2016). Modalités de préparation, cryopréservation, décongélation des cellules souches hématopoïétiques et précautions pour infusion au patient: recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. doi:10.1016/j.bulcan.2016.09.002
Peer Reviewed verified by ORBi

Saccardi, R., Tucunduva, L., Ruggeri, A., Ionescu, I., Koegler, G., Querol, S., Grazzini, G., Lecchi, L., Nanni Costa, A., Navarrete, C., Pouthier, F., Larghero, J., Regan, D., Freeman, T., Bittencourt, H., Kenzey, C., Labopin, M., BAUDOUX, E., Rocha, V., & Gluckman, E. (31 May 2016). Impact of cord blood banking technologies on clinical outcome: a Eurocord/Cord Blood Committee (CTIWP), European Society for Blood and Marrow Transplantation and NetCord retrospective analysis. Transfusion, 56 (8), 2021-2029. doi:10.1111/trf.13661
Peer Reviewed verified by ORBi

SERVAIS, S., GREGOIRE, C., BARON, F., WILLEMS, E., BRIQUET, A., BAUDOUX, E., DELLOYE, O., GIET, O., LECHANTEUR, C., & BEGUIN, Y. (2016). Multipotent mesenchymal stromal cell therapy for steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation. Belgian Journal of Hematology, 7, 229-235.
Peer Reviewed verified by ORBi

LECHANTEUR, C., BRIQUET, A., GIET, O., DELLOYE, O., BAUDOUX, E., & BEGUIN, Y. (2016). Clinical - scale expansion of mesenchymal stromal cells: a large banking experience. Journal of Translational Medicine, 14, 145-159. doi:10.1186/s12967-016-0892-y
Peer Reviewed verified by ORBi

Rouard, H., Boulanger, F., BAUDOUX, E., Calmels, B., de Vos, J., Gautier, E., Lacassagne, M. N., Tirefort, Y., Turlure, P., Chabannon, C., GERARD, C., GIET, O., Letellier, C., MONFORT, M., Thibert, J.-B., & Yakoub-Agha, I. (December 2015). Bone marrow processing for hematopoietic stem cell transplantation: recommendations of the SFGM-TC. Hématologie, 21 (Supp 3), 42-46. doi:10.1684/hma.2015.1070
Peer reviewed

Pirnay, J. P., BAUDOUX, E., Cornu, O., Delforge, A., Delloye, C., Guns, J., Heinen, E., Van den Abbeel, E., Vanderkelen, A., Van Geyt, C., van Riet, I., Verbeken, G., De Sutter, P., Verlinden, M., Huys, I., Cockbain, J., Chabannon, C., Dierickx, K., Schotsmans, P., ... Sterckx, S. (07 April 2015). Access to human tissues for research and product development. EMBO Reports, 16 (5), 1-6. doi:10.15252/embr.201540070
Peer Reviewed verified by ORBi

Saccardi, R., Azqueta, C., Ballerini, C., Ballerini, L., BAUDOUX, E., Caporale, R., Dal Pozzo, S., Gomez, S., Kogler, G., Lanza, F., Angelotti, M., Madrigal, A., Ongari, M., Querol, S., Radke, T., Rocha, V., Ruggeri, A., Urbani, S., & Gluckman, E. (2015). Modification of standard ISHAGE methodology for CD34+ cells count on thawed Cord Blood Units: results from a multi-center Eurocord/Netcord study. Bone Marrow Transplantation, 50, 562.
Peer Reviewed verified by ORBi

Binsfeld, M., HANNON, M., Otjacques, E., Humblet-Baron, S., BAUDOUX, E., BEGUIN, Y., BARON, F., & CAERS, J. (2015). Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation. Cancer Immunology, Immunotherapy, 64, 989-998. doi:10.1007/s00262-015-1708-2
Peer Reviewed verified by ORBi

Servais, S., BAUDOUX, E., Brichard, B., Bron, D., Debruyn, C., De Bruyère, M., De Hemptinne, D., Deneys, V., Paulus, J.-M., Raymakers, N., Schaaps, J.-P., Van Cauwenberge, J., Cornu, G., Delforge, A., & Beguin, Y. (January 2015). Circadian and circannual variations in cord blood hematopoietic cell composition. Haematologica, 100 (1), 32-34. doi:10.3324/haematol.2014.115394
Peer Reviewed verified by ORBi

SACCARDI, R., AZQUETA, C., BALLERINI, L., BAUDOUX, E., DAL POZZO, S., GOMEZ, S., KOGLER, G., LANZA, F., ONGARI, M., QUEROL, S., FALK RADKE, T., ROCHA, V., RUGGERI, A., URBANI, S., & GLUCKMAN, E. (06 December 2014). Flow Cytometry Assessment of CD34+ Viability in Thawed Cord Blood Units: A Multi-Center Eurocord and Netcord Study. Blood, 124.
Peer Reviewed verified by ORBi

DETRY, O., JOURET, F., VANDERMEULEN, M., ERPICUM, P., Delens, L., GREGOIRE, C., BRIQUET, A., WEEKERS, L., BAUDOUX, E., LECHANTEUR, C., & BEGUIN, Y. (December 2014). Cellules stromales mésenchymateuses et transplantation d'organes. Revue Médicale de Liège, 69, 53-56.
Peer reviewed

RUGGERI, A., LABOPIN, M., SORMANI, M. P., SANZ, G., SANZ, J., VOLT, F., MICHEL, G., LOCATELLI, F., DIAZ DE HEREDIA, C., O’BRIEN, T., ARCESE, W., IORI, A. P., QUEROL, S., KOGLER, G., LECCHI, L., POUTHIER, F., GARNIER, F., NAVARRETE, C., BAUDOUX, E., ... SACCARDI, R. (September 2014). Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen. Haematologica, 99, 1509-1515. doi:10.3324/haematol.2014.109280
Peer Reviewed verified by ORBi

CALMELS, Boulanger, F., BAUDOUX, E., Decot, V., Fawaz, A., Giraud, C., Hivert, B., Garderet, L., Milpied, N., & Yakoub-Agha. (01 July 2014). Modalités de conservation et de destruction des produits cellulaires cryopréservés : recommandations de la SFGM-TC. Pathologie Biologie, 62 (3). doi:10.1016/j.patbio.2014.05.006
Peer Reviewed verified by ORBi

De Vos, J., Birebent, B., Faucher, C., GIET, O., Hicheri, Y., Lemarie, C., BAUDOUX, E., Garnier, F., Larghero, J., Pouthier, F., Thibert, J., & Yakoub-Agha, I. (2014). Contrôle de qualité des USP via segments attachés : recommandations de la SFGM-TC. Pathologie Biologie. doi:10.1016/j.patbio.2014.05.005
Peer Reviewed verified by ORBi

Hannon, M., LECHANTEUR, C., Lucas, S., Somja, J., Seidel, L., Belle, L., Bruck, F., BAUDOUX, E., GIET, O., Chantillon, A.-M., Delvenne, P., Drion, P., Beguin, Y., Humblet-Baron, S., & Baron, F. (17 June 2014). Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease. Transfusion, 54 (February), 353-363. doi:10.1111/trf.12279
Peer Reviewed verified by ORBi

Baron, F., Humblet-Baron, S., Ehx, G., SERVAIS, S., HANNON, M., Belle, L., LECHANTEUR, C., BRIQUET, A., GIET, O., BAUDOUX, E., WILLEMS, E., & Beguin, Y. (2014). Thinking out of the box - New approaches to controlling GVHD. Current Hematologic Malignancy Reports, 9, 73-84. doi:10.1007/s11899-013-0187-9
Peer Reviewed verified by ORBi

LECHANTEUR, C., Baila, S., Janssen, M. E., GIET, O., BRIQUET, A., BAUDOUX, E., & Beguin, Y. (2014). Large-Scale Clinical Expansion of Mesenchymal Stem Cells in the GMP-Compliant, Closed Automated Quantum® Cell Expansion System: Comparison with Expansion in Traditional T-Flasks. Journal of Stem Cell Research and Therapy, 4 (8), 1000222. doi:10.4172/2157- 7633.1000222
Peer Reviewed verified by ORBi

MOERMANS, C., LECHANTEUR, C., BAUDOUX, E., GIET, O., HENKET, M., SEIDEL, L., LEJEUNE, M., WILLEMS, E., Baron, F., LOUIS, R., & BEGUIN, Y. (2014). Impact of cotransplantation of mesenchymal stem cells on lung function after unrelated allogeneic hematopoietic stem cell transplantation following non-myeloablative conditioning. Transplantation, 98 (3), 348-353. doi:10.1097/TP.0000000000000068
Peer Reviewed verified by ORBi

Klykens, J., Pirnay, J., Verbeken, G., GIET, O., BAUDOUX, E., Jashari, R., Vanderkelen, A., & Ectors, N. (2013). Cleanrooms and tissue banking how happy I could be with either GMP or GTP? Cell and Tissue Banking. doi:10.1007/s10561-012-9355-8
Peer Reviewed verified by ORBi

Rocha, V., Spellman, S., Zhang, M., Ruggeri, A., Purtill, D., Brady, C., Baxter-Lowe, L., BAUDOUX, E., Bergamaschi, P., Chow, R., Freed, B., Koegler, G., Kurtzberg, J., Larghero, J., Lecchi, L., Nagler, A., Navarette, C., Prasad, V., Pouthier, F., ... Eapen, M. (2012). Effect of HLA-matching recipients to donor non-inherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. Biology of Blood and Marrow Transplantation.
Peer Reviewed verified by ORBi

PIRNAY, J., ECTORS, N., DELLOYE, C., DUFRANE, D., BAUDOUX, E., VAN BRUSSEL, M., CASAER, M., DE VOS, D., DRAYE, J., ROSE, T., JENNES, S., NEIRINCKX, P., LAIRE, G., ZIZI, M., & VERBEKEN, G. (2012). Beware of the commercialization of human cells and tissues: situation in the European Union. Cell and Tissue Banking. doi:10.1007/s10561-012-9323-3
Peer Reviewed verified by ORBi

GLUCKMAN, E., ROCHA, V., BAUDOUX, E., BOO, M., KURTZBERG, J., WELTE, K., NAVARRETE, C., & VAN WALRAVEN, S. (12 July 2011). Family-directed umbilical cord blood banking. Haematologica, 96 (11), 1700-17007. doi:10.3324/haematol.2011.047050
Peer Reviewed verified by ORBi

Baron, F., Lechanteur, C., Willems, E., Bruck, F., Baudoux, E., Seidel, L., Vanbellinghen, J.-F., Hafraoui, K., LEJEUNE, M., Gothot, A., Fillet, G., & Beguin, Y. (2010). Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Biology of Blood and Marrow Transplantation, 16 (6), 838-47. doi:10.1016/j.bbmt.2010.01.011
Peer Reviewed verified by ORBi

Willems, E.* , Baron, F.* , Baudoux, E., Wanten, N., Seidel, L., Vanbellinghen, J.-F., Herens, C., Gothot, A., Frere, P., Bonnet, C., Hafraoui, K., Vanstraelen, G., Fillet, G., & Beguin, Y. (2009). Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial. Leukemia, 23 (3), 608-10. doi:10.1038/leu.2008.248
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Brand, A., Rebulla, P., Engelfriet, C. P., Reesink, H. W., Beguin, Y., Baudoux, E., Kögler, G., Ebrahimi, M., Grazzini, G., Costa, A. N., Bosi, A., Sacchi, S., Lombardini, L., Pupella, S., Lecchi, L., Calderon Garciduenas, E. D., van Beckhoven, J. M., de Wit, H. J. C., Fibbe, W. E., ... Regan, F. (2008). Cord blood banking. Vox Sanguinis, 95, 335-348. doi:10.1111/j.1423-0410.2008.01106.x
Peer Reviewed verified by ORBi

Bovy, C., Baudoux, E., Salmon, J., & Beguin, Y. (2006). Increased iron absorption during autologous blood donation supported by recombinant human erythropoietin therapy. Transfusion, 46 (9), 1616-23. doi:10.1111/j.1537-2995.2006.00945.x
Peer Reviewed verified by ORBi

Baron, F., Copizza, S., Baudoux, E., Jerusalem, G., Fillet, G., & Beguin, Y. (2004). CD34+ cell dose predicts costs after autologous peripheral blood stem cell transplantation for breast cancer. Haematologica, 89 (9), 1146-8.
Peer Reviewed verified by ORBi

Andre, M., Baudoux, E., Bron, D., Canon, J.-L., D'Hondt, V., Fassotte, M.-F., D'Hondt, L., Fillet, G., Humblet, Y., Jerusalem, G., Vermeulen, P., Symann, M., & Beguin, Y. (2003). Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies. Transfusion, 43 (1), 50-7. doi:10.1046/j.1537-2995.2003.00273.x
Peer Reviewed verified by ORBi

Baron, F., Schaaf-Lafontaine, N., Humblet-Baron, S., Meuris, N., Castermans, E., Baudoux, E., Frere, P., Bours, V., Fillet, G., & Beguin, Y. (2003). T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation. Transplantation, 76 (12), 1705-13. doi:10.1097/01.TP.0000093987.11389.F7
Peer Reviewed verified by ORBi

Baron, F., Frere, P., Baudoux, E., Sautois, B., Fillet, G., & Beguin, Y. (2003). Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma. Haematologica, 88 (4), 478-80.
Peer Reviewed verified by ORBi

Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N., Herens, C., De Prijck, B., Fillet, G., & Beguin, Y. (2003). Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSC. Bone Marrow Transplantation, 32 (8), 829-34. doi:10.1038/sj.bmt.1704220
Peer Reviewed verified by ORBi

Baron, F., Frere, P., Baudoux, E., Schaaf-Lafontaine, N., Fillet, G., & Beguin, Y. (2003). Low incidence of acute graft-versus-host disease after non-myeloablative stem cell transplantation with CD8-depleted peripheral blood stem cells: an update. Haematologica, 88 (7), 835-7.
Peer Reviewed verified by ORBi

Baron, F., Sautois, B., Baudoux, E., Matus, G., Fillet, G., & Beguin, Y. (2002). Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation. Experimental Hematology, 30 (6), 546-54. doi:10.1016/S0301-472X(02)00795-6
Peer reviewed

Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N., Greimers, R., Herens, C., Fillet, G., & Beguin, Y. (2002). Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells. Journal of Hematotherapy and Stem Cell Research, 11 (2), 301-14. doi:10.1089/152581602753658484
Peer Reviewed verified by ORBi

Baron, F., Siquet, J., Schaaf-Lafontaine, N., Baudoux, E., Hermanne, J.-P., Fillet, G., & Beguin, Y. (2002). Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation. Haematologica, 87 (1), 78-88.
Peer Reviewed verified by ORBi

Baron, F., Baudoux, E., Fillet, G., & Beguin, Y. (2002). Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation. Hematology, 7 (3), 137-43. doi:10.1080/1024533021000008173
Peer Reviewed verified by ORBi

Engelfriet, C. P., Reesink, H. W., Wagner, J. E., Kogler, G., Rocha, V., Wernet, P., Lecchi, L., Lazzari, L., Ratti, I., Giovanelli, S., Poli, F., Rebulla, P., Beguin, Y., Baudoux, E., Navarrete, C., Armitage, S., Laughlin, M. J., & McClelland, W. M. (2002). International forum. Use of umbilical cord blood progenitor cells as an alternative for bone marrow transplantation. Vox Sanguinis, 83 (2), 172-87. doi:10.1046/j.1423-0410.2002.00197.x
Peer Reviewed verified by ORBi

Sautois, B., Baudoux, E., Salmon, J., Michaux, S., Schaaf-Lafontaine, N., Pereira-Martins, M., Paulus, J.-M., Fillet, G., & Beguin, Y. (2001). Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation. Haematologica, 86 (11), 1209-18.
Peer Reviewed verified by ORBi

Fraipont, V., Sautois, B., Baudoux, E., Pereira-Martins, M., Fassotte, M.-F., Hermanne, J. P., Jerusalem, G., Longree, L., Schaaf-Lafontaine, N., Fillet, G., & Beguin, Y. (2000). Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF. Transfusion, 40 (3), 339-47. doi:10.1046/j.1537-2995.2000.40030339.x
Peer Reviewed verified by ORBi

Baudoux, E., Blaffart, F., Bouffioux, C., Caprasse, M., Courtois, F., Cremasco, M.-R., De Pasqual, E., Fassotte, M.-F., Gillet, P., Lamy, M., Larbuisson, R., Lemaire, R., Merciny, M., Moutschen, M., Radermecker, M., Remy, B., & Sondag, D. (2000). La commission d'hemovigilance du CHU. Revue Médicale de Liège, 55 (9), 878-80.
Peer reviewed

Sautois, B., Fraipont, V., Baudoux, E., Fassotte, M.-F., Hermanne, J. P., Jerusalem, G., Bours, V., Bosquee, L., Schaaf-Lafontaine, N., Paulus, J.-M., Sondag, D., Fillet, G., & Beguin, Y. (1999). Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields. Haematologica, 84 (4), 342-9.
Peer Reviewed verified by ORBi

Salmon, J., Michaux, S., Hermanne, J. P., Baudoux, E., Gerard, C., Sondag, D., Fillet, G., & Beguin, Y. (1999). Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation. Transfusion, 39 (8), 824-7. doi:10.1046/j.1537-2995.1999.39080824.x
Peer Reviewed verified by ORBi

Beguin, Y., Baudoux, E., Sautois, B., Fraipont, V., Schaaf-Lafontaine, N., Pereira-Martins, M., Paulus, J.-M., Sondag, D., & Fillet, G. (1998). Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells. Transfusion, 38 (2), 199-208. doi:10.1046/j.1537-2995.1998.38298193106.x
Peer Reviewed verified by ORBi

Baudoux, E., Margraff, U., Coenen, A., Jacobs, X., Deboutez, M., Lungu, C., & Sondag-Thull, D. (1998). Hemovigilance: Clinical Tolerance of Solvent-Detergent Treated Plasma. Vox Sanguinis, 74 (Suppl 1), 237-9. doi:10.1111/j.1423-0410.1998.tb05479.x
Peer Reviewed verified by ORBi

Jacquet, M., LAMBERT, V., BAUDOUX, E., Muller, M., Kremers, P., & Gielen, J. (April 1996). Correlation between P450 CYP1A1 Indelibility, MsPI Genotype and Lung Cancer Incidence. European Journal of Cancer, 32A (10), 1701-1706.
Peer Reviewed verified by ORBi

Scientific congresses and symposiums

Published communications

Rafii, H., Kenzey, C., Volt, F., Sanz, J., Michel, G., Dalle, J. H., Kleinschmidt, K., BAUDOUX, E., QUEROL, S., Ruggeri, A., Chabannon, C., & Gluckman, E. (11 December 2020). Optimizing Outcomes of Acute Leukemia After Transplants with Single Unrelated Cord Blood Units Selected According to Current International Recommendations for Cell Dose and HLA Match. Bone Marrow Transplantation, 55 (4), 170-171.
Peer Reviewed verified by ORBi

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., GIET, O., BAUDOUX, E., Hannon, M., Baron, F., & BEGUIN, Y. (January 2017). UNE INJECTION UNIQUE DE CELLULES STROMALES MESENCHYMATEUSES AU JOUR 3 APRES GREFFE HEPATIQUE EST INSUFFISANTE POUR INDUIRE UNE TOLERANCE OPERATIONNELLE. Transplant International, 30 (suppl 1), 8 (O12.
Peer Reviewed verified by ORBi

HAUZEUR, J.-P., Tungouz, M., LECHANTEUR, C., Beguin, Y., BAUDOUX, E., de maertelaer, V., Pather, S., Katz, R., Ino, J., Egrise, D., Malaise, M., & Gangji, V. (October 2016). Ostéoblastes autologues (PREOB®) versus concentré de moelle autologue dans l’ostéonécrose de la tête fémorale : étude randomisée. Revue de Chirurgie Orthopédique et Traumatologie, 102, 73. doi:10.1016/j.rcot.2016.08.002
Peer reviewed

WEEKERS, L., Erpicum, P., DETRY, O., BONVOISIN, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (2016). administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up. Transplant International, 29 (Suppl 2), 13 -p6.
Peer Reviewed verified by ORBi

WEEKERS, L., ERPICUM, P., DETRY, O., JOURET, F., LECHANTEUR, C., DELBOUILLE, M.-H., BRIQUET, A., BAUDOUX, E., & BEGUIN, Y. (November 2015). Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis. Transplant International, 28 (S4), 223-224/BO278.
Peer Reviewed verified by ORBi

WEEKERS, L., ERPICUM, P., DETRY, O., LECHANTEUR, C., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (May 2015). Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis. American Journal of Transplantation, 15 (suppl 3).
Peer Reviewed verified by ORBi

BAUDOUX, E. (2013). Cord blood banking Introduction-State of the art. In E. Gluckman & Cavazzana (Eds.), World Cord blood congress IV and innovative therapies for sickle cell disease.

SACCARDI, R., Tucunduva, L., Ruggeri, A., Ionescu, I., Koegler, G., Querol, S., Lecchi, L., Pouthier, F., Bittencourt, H., Kenzey, C., Gluckman, E., Labopin, M., BAUDOUX, E., & Rocha, V. (01 April 2013). Effect of volume reduction of cord blood units before storage on transplantation outcomes: a retrospective analysis of Eurocord-EBMT and Netcord. Bone Marrow Transplantation, 48, 34.
Peer Reviewed verified by ORBi

WILLEMS, E., CASTERMANS, E., Baron, F., BAUDOUX, E., Wanten, N., Bonnet, C., HAFRAOUI, K., Frère, P., Fillet, G., & Beguin, Y. (2005). Nonmyeloablative stem cell transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a prospective randomized trial. Blood, 106 (1075).
Peer Reviewed verified by ORBi

Oral communications or posters

VIEUJEAN, S., LOLY, J.-P., BOUTAFFALA, L., MEUNIER, P., REENAERS, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., BEGUIN, Y., & LOUIS, E. (October 2021). Local Mesenchymal Stem Cells injection in Crohn’s disease strictures: a phase I-II, open-label clinical study [Poster presentation]. United European Gastroenterology.
Peer reviewed

WEEKERS, L., ERPICUM, P., DETRY, O., BONVOISIN, C., DELBOUILLE, M.-H., LECHANTEUR, C., BRIQUET, A., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (16 March 2017). Administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up [Paper presentation]. 24th Annual Meeting, Bruxelles, Belgium.

BAUDOUX, E. (16 November 2016). Sang de cordon état des lieux et perspectives [Paper presentation]. Congrès commun SFGM-TC 16e CONGRES et de la SFBCT 8e CONGRES, Liège, Belgium.

Erpicum, P., WEEKERS, L., DETRY, O., BONVOISIN, C., LECHANTEUR, C., BRIQUET, A., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (28 April 2016). Administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up [Paper presentation]. Annual Meeting of the BVN-SBN, Bruxelles, Belgium.

Grégoire, C., Beguin, Y., Hannon, M., DUBOIS, S., BAUDOUX, E., BRIQUET, A., LECHANTEUR, C., Ehx, G., & Baron, F. (29 January 2016). Umbilical cord mesenchymal stromal cells are superior to bone marrow and adipose tissue-derived mesenchymal stromal cells for the treatment of xenogeneic graft-versus-host disease in mice [Poster presentation]. 31th General Meeting of the Belgian Hematological Society.

BAUDOUX, E., Lefebvre, C., & FASTH, A. (16 May 2014). CORD DONOR Safety [Paper presentation]. International Donor Registry Conference 2014, London, United Kingdom.

DETRY, O., DELBOUILLE, M.-H., LECHANTEUR, C., SOMJA, J., DE ROOVER, A., WEEKERS, L., SQUIFFLET, J.-P., Honoré, P., DELVENNE, P., MEURISSE, M., BAUDOUX, E., & BEGUIN, Y. (30 May 2013). INFUSION OF THIRD-PARTY MESENCHYMAL STEM CELLS (MSC) AFTER KIDNEY AND LIVER TRANSPLANTATION: A PHASE I-II, OPEN-LABEL, CLINICAL STUDY (EudraCT 2011-001822-81 & NCT01429038) [Poster presentation]. 13eme rencontre de Beaune, Beaune, France.

DETRY, O., DELBOUILLE, M.-H., LECHANTEUR, C., SOMJA, J., DE ROOVER, A., WEEKERS, L., DELVENNE, P., BAUDOUX, E., & BEGUIN, Y. (19 October 2012). Infusion of third party mesenchymal stem cells (MSC) after kidney and liver transplantation: a phase I-II, open-label, clinical study [Paper presentation]. 4th Expert meeting, Barcelona, Spain.

Baron, F., WILLEMS, E., LECHANTEUR, C., BAUDOUX, E., Frere, P., Vanbellinghen, J., Bruck, F., Gothot, A., HAFRAOUI, K., Fillet, G., & Beguin, Y. (2009). Co-transplantation of mesenchymal stem cells might mitigate acute GvHD without abrogating graftversus- tumour alloreactivity after allogeneic transplantation with non-myeloablative conditioning [Paper presentation]. 35th EBMT Annual Meeting.

WILLEMS, E., CASTERMANS, E., Baron, F., BAUDOUX, E., Wanten, N., Bonnet, C., HAFRAOUI, K., Frère, P., Fillet, G., & Beguin, Y. (2006). Nonmyeloablative stem cell transplantation with CD8-depleted or unmalipulated peripheral blood stem cells: a prospective randomized trial [Paper presentation]. 21st General Meeting of the Belgian Hematological Society.

Book chapters and contributions to collective works

GREGOIRE, C., Louis, E., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., GIET, O., Beguin, Y., & BARON, F. (2017). The role of mesenchymal stromal cells in the treatment of ulcerative colitis and Crohn’s disease. In The Biology and Therapeutic Application of Mesenchymal Cells (pp. 730-753). Hoboken, United States: John Wiley & Sons, Inc.
Peer reviewed

GREGOIRE, C., DETRY, O., Jouret, F., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., Beguin, Y., & GIET, O. (2017). The use of mesenchymal stromal cells in solid organ transplantation. In The Biology and Therapeutic Application of Mesenchymal Cells (pp. 825-835). Hoboken, United States: John Willey & Sons, Inc.
Peer reviewed

Van Beckhoven, J., BAUDOUX, E., Duffy, M., Elmoazzen, H., Elwood, N., Gluckman, E., Gomez, S., Korhonen, M., Maeck, J., Querol, S., Ruggeri, A., & Torrabadella, M. (2013). Cord Blood Banking: Cord blood management and evaluation: International networking. In W. Hwang, M. Boo, ... T. Bart (Eds.), A gift for life, WMDA handbook for blood stem cell donation (pp. 178-180). WMDA.

Baudoux, E., Janssens, M., Beguin, Y., Sondag, D., Fillet, G., & Lamy, M. (1993). Erythropoietin in surgery. In Proceedings of the 4th Regional Congress of the International Society of Blood Transfusion (pp. 213-217).

Expert reports

BAUDOUX, E., BEGUIN, Y., Benoit, Y., Billiet, J., Delforge, A., DEVOS, T., Latinne, D., Noens, L., Selleslag, D., Van Riet, I., VANDEKERCKHOVE, B., Vermylen, C., & Zachée, P. (2012). Cord blood for allogeneic use: Clinical and scientific aspects? (8784). Bruxelles, Belgium: Conseil Supérieur de la Santé. https://orbi.uliege.be/handle/2268/153938

Angenon, E., BAUDOUX, E., BEGUIN, Y., benoit, Y., Billiet, J., Delforge, A., Devos, T., Ferrant, A., KÖGLER, G., Latinne, D., Faucher, C., NAVARRETE, C., Noens, L., SELLESLAG, D., STRAETMANS, N., VAN RIET, I., & Zachée, P. (2011). Autologous cord blood use: Clinical and scientific aspects. (8677). https://orbi.uliege.be/handle/2268/153939

Learning materials

Others

BAUDOUX, E., GIET, O., Jöris, M., Byam, C., Rocha, V., Ionescu, I., & Elmoazzen, H. (2016). Importing and Exporting Cord Blood Units. (Foundation for the Accreditation of Cellular Therapies).

BAUDOUX, E. (2012). Donor and stem cell source selection. (Belgian Hematological Society, Donor and stem cell source selection).

Other publications and communications

Articles in scientific journals without peer reviewing

GREGOIRE, C., SERVAIS, S., WILLEMS, E., BAUDOUX, E., LECHANTEUR, C., BRIQUET, A., Bettonville, V., DETRY, O., ERPICUM, P., JOURET, F., LOUIS, E., BARON, F., & BEGUIN, Y. (April 2022). Immunothérapie cellulaire au CHU de Liège : avancées, défis et perspectives. Revue Médicale de Liège, 77 (4), 206-211.
Editorial Reviewed verified by ORBi

Baudoux, E. (April 1996). Autologous Blood Donation Plus Epoetin Alfa in Nonanemic Orthopedic Surgery Patients. Seminars in Hematology, 33 (2 Suppl 2), 31-2, discussion 33.

Contact ORBi